How we manage haemostasis during sepsis

How I treat How we manage venous thromboembolism during pregnancy

During pregnancy, physiologic and anatomic changes can complicate the diagnosis of venous thromboembolism (VTE) as well as the management of patients with a high risk of or established VTE. As in nonpregnant subjects, clinical diagnosis of VTE by itself is unreliable and accurate objective testing is essential. Few diagnostic studies of VTE have been performed in pregnant women and, therefore, ...

How should we manage incidentalomas?

The patient-centered medical home model advocates that diagnostic testing be performed based on shared decision making between the patient and physician.1 This goal can be challenging when findings are uncertain or incidental to the original reason for ordering the test. For this reason, it would be useful for physicians to have guidelines to help address the ethical, practical, and legal impli...

How should we manage oral leukoplakia?

The aim of this article is to review the management of oral leukoplakia. The topics of interest are clinical diagnosis, methods of management and their outcome, factors associated with malignant transformation, prognosis, and clinical follow-up. Global prevalence is estimated to range from 0.5 to 3.4%. The point prevalence is estimated to be 2.6% (95% CI 1.72-2.74) with a reported rate of malig...

How should we diagnose and manage photosensitivity?

How do we manage cardiopulmonary bypass coagulopathy?

BACKGROUND Patients who undergo cardiopulmonary bypass (CPB) are at risk for coagulopathy. Suboptimal turnaround time (TAT) of laboratory coagulation testing results in empiric administration of blood products to treat massive bleeding. We describe our initiative in establishing the coagulation-based hemotherapy (CBH) service, a clinical pathology consultation service that uses rapid TAT coagul...